of total actual respiratory infection cases are undiagnosed
> 97%
annual cost of respiratory viral infections in the EU and US
$100B
With the majority of cases remaining undiagnosed and a significant risk of future pandemics, earlier and faster diagnosis is key to reducing the spread of emerging viral infections, enabling timely treatment and mitigating their burden.
A seamless, non-invasive and rapid diagnostic process
The patient feels unwell or is suspected of being infected
The patient breathes into the device. The pathogen is identified within 3 minutes and displayed on the VAir GO screen.
The patient breathes into the device. The pathogen is identified within 3 minutes and displayed on the VAir GO screen
Diagnostic results are automatically transferred to the Electronic Medical Record (EMR)
For the next test, the sterile tip is replaced and the device is disinfected. Any viruses inside the device are then inactivated
VAir’s non-invasive technology outperforms traditional diagnostic tools